Activity of CoII–Quinalizarin: A Novel Analogue of Anthracycline-Based Anticancer Agents Targets Human DNA Topoisomerase, Whereas Quinalizarin Itself Acts via Formation of Semiquinone on Acute Lymphoblastic Leukemia MOLT‑4 and HCT 116 Cells
Main Authors: | Sayantani Mukherjee Chatterjee, Chetan Kumar Jain, Soumen Singha, Piyal Das, Susanta Roychoudhury, Hemanta Kumar Majumder, Saurabh Das |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2018-08-01
|
Series: | ACS Omega |
Online Access: | http://dx.doi.org/10.1021/acsomega.8b00706 |
Similar Items
-
Spectrophotometric determination of rosuvastatin in pharmaceutical formulations using quinalizarin
by: Monica Força Lima, et al.
Published: (2017-07-01) -
Spectrophotometric Assay of Noradrenaline in Pharmaceutical Formulation with Quinalizarin in Aqueous Solution
by: Thabit S. Al-Ghabsha, et al.
Published: (2012-06-01) -
Solvent Extraction and Spectrophotometric Determination of Magnesium by Paratoly l-2-Thenohydroxamic Acid and Quinalizarin
by: Nasser Dallali, et al.
Published: (2004-04-01) -
Quinalizarin as a potential antifungal drug for the treatment of Candida albicans fungal infection in cancer patients
by: Monika Janeczko, et al.
Published: (2024-03-01) -
Field method for estimation of fluoride in drinking groundwater by photometric measurement of spot on aluminium quinalizarin reagent paper
by: Zaher Barghouthi, et al.
Published: (2017-05-01)